{"DataElement":{"publicId":"13479883","version":"1","preferredName":"Protocol Agent Route of Administration Type","preferredDefinition":"The way in which a medication is introduced into the body.","longName":"13381594v1.00:13479881v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13381594","version":"1","preferredName":"Protocol Agent Route of Administration","preferredDefinition":"A medical product, practice, or application that is tested in a clinical trial.:Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","longName":"2390874v1.00:2437708v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2390874","version":"1","preferredName":"Protocol Agent","preferredDefinition":"A therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.","longName":"C41161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol Agent","conceptCode":"C41161","definition":"A medical product, practice, or application that is tested in a clinical trial.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE52ECB4-C771-617F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-08-19","modifiedBy":"ONEDATA","dateModified":"2005-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2437708","version":"1","preferredName":"Route of Administration","preferredDefinition":"The course by which a substance was administered in order to reach the site of action in the body.","longName":"C38114","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07F9A295-F47D-5DFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9B6AE2E-EECC-20B3-E053-731AD00AA622","latestVersionIndicator":"Yes","beginDate":"2023-04-19","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-19","modifiedBy":"FINCHAMB","dateModified":"2023-11-12","changeDescription":null,"administrativeNotes":"11/12/23 Released per PCDC-U of Chicago/Mei Li. BF;4/24/2023: added Origin to DEC.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13479881","version":"1","preferredName":"Route of Administration Type","preferredDefinition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration._Something distinguishable as an identifiable class based on common qualities.","longName":"13479881v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intrathecal","valueDescription":null,"ValueMeaning":{"publicId":"5335406","version":"1","preferredName":"Intrathecal Route of Administration","longName":"5335406","preferredDefinition":"Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrathecal Route of Administration","conceptCode":"C38267","definition":"Administration of drugs directly into spinal subarachnoid space in the cerebrospinal fluid, at any level of the cerebrospinal axis, including injection into the cerebral ventricles, in order to bypass the blood-brain barrier and achieve local, rapid effects on the meninges or cerebrospinal axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36E51D41-9FA3-74F7-E050-BB89AD4334C4","latestVersionIndicator":"Yes","beginDate":"2016-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FAC90E89-CAF5-0F29-E053-731AD00ACA40","beginDate":"2023-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-03","modifiedBy":"SOKKERL","dateModified":"2023-05-03","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FAC90E89-CAF6-0F29-E053-731AD00ACA40","beginDate":"2023-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-03","modifiedBy":"SOKKERL","dateModified":"2023-05-03","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FAC90E89-CAF7-0F29-E053-731AD00ACA40","beginDate":"2023-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-03","modifiedBy":"SOKKERL","dateModified":"2023-05-03","deletedIndicator":"No"},{"value":"Intravenously","valueDescription":null,"ValueMeaning":{"publicId":"5335410","version":"1","preferredName":"Intravenous Route of Administration","longName":"5335410","preferredDefinition":"Administration within or into a vein or veins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Route of Administration","conceptCode":"C38276","definition":"Administration of a drug within or into a vein or veins. Introduction of the drug directly into venous circulation results in 100% bioavailability due to an absence of the absorption phase, provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36E51D41-9FEF-74F7-E050-BB89AD4334C4","latestVersionIndicator":"Yes","beginDate":"2016-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-05","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FAC90E89-CAF8-0F29-E053-731AD00ACA40","beginDate":"2023-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-03","modifiedBy":"SOKKERL","dateModified":"2023-05-03","deletedIndicator":"No"},{"value":"Intraarterial","valueDescription":null,"ValueMeaning":{"publicId":"2578037","version":"1","preferredName":"Intraarterial Route of Administration","longName":"2578037","preferredDefinition":"Administration within an artery or arteries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraarterial Route of Administration","conceptCode":"C38222","definition":"The administration of a substance directly into an artery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FAC90E89-CAF9-0F29-E053-731AD00ACA40","beginDate":"2023-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-03","modifiedBy":"SOKKERL","dateModified":"2023-05-03","deletedIndicator":"No"},{"value":"Intracameral","valueDescription":null,"ValueMeaning":{"publicId":"6412735","version":"1","preferredName":"Intracameral Route of Administration","longName":"6412735","preferredDefinition":"Administration of a substance by injection directly into the anterior chamber of the eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracameral Route of Administration","conceptCode":"C64984","definition":"Administration of a medicinal product directly into the anterior chamber of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74317350-C6F7-0B55-E053-F662850A47B7","latestVersionIndicator":"Yes","beginDate":"2018-08-24","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-08-24","modifiedBy":"ONEDATA","dateModified":"2018-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FAC90E89-CAFA-0F29-E053-731AD00ACA40","beginDate":"2023-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-03","modifiedBy":"SOKKERL","dateModified":"2023-05-03","deletedIndicator":"No"},{"value":"Intravitreal","valueDescription":null,"ValueMeaning":{"publicId":"2578051","version":"1","preferredName":"Intravitreal Route of Administration","longName":"2578051","preferredDefinition":"Administration within the vitreous body of the eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravitreal Route of Administration","conceptCode":"C38280","definition":"The administration of a drug within the vitreous body of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDF0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FAC90E89-CAFB-0F29-E053-731AD00ACA40","beginDate":"2023-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-03","modifiedBy":"SOKKERL","dateModified":"2023-05-03","deletedIndicator":"No"},{"value":"Transscleral","valueDescription":null,"ValueMeaning":{"publicId":"13750997","version":"1","preferredName":"Transscleral Route of Administration","longName":"13750997v1.00","preferredDefinition":"Administration of a drug to the posterior segment of the eye, either by direct injection through or diffusion across the sclera.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transscleral Route of Administration","conceptCode":"C199207","definition":"Administration of a drug to the posterior segment of the eye, either by direct injection through or diffusion across the sclera.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEAA696-30FD-1E80-E053-731AD00AF5C3","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-30","modifiedBy":"COLBERTM","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCEAA696-30FF-1E80-E053-731AD00AF5C3","beginDate":"2023-05-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-30","modifiedBy":"COLBERTM","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"Systemic","valueDescription":null,"ValueMeaning":{"publicId":"13750998","version":"1","preferredName":"Systemic Route of Administration","longName":"13750998v1.00","preferredDefinition":"Administration of a drug into the blood circulation for delivery throughout the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic Route of Administration","conceptCode":"C199208","definition":"Administration of a drug into the blood circulation for delivery throughout the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEAA696-30FE-1E80-E053-731AD00AF5C3","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-30","modifiedBy":"COLBERTM","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCEAA696-3100-1E80-E053-731AD00AF5C3","beginDate":"2023-05-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-30","modifiedBy":"COLBERTM","dateModified":"2023-05-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2486825","version":"1","preferredName":"Route of Administration Type","preferredDefinition":"The course by which a substance was administered in order to reach the site of action in the body.:Type; a subdivision of a particular kind of thing.","longName":"C38114:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16358911-63C0-2575-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-14","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-14","modifiedBy":"ONEDATA","dateModified":"2006-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FABB6322-8A2B-24A7-E053-731AD00A3B0D","latestVersionIndicator":"Yes","beginDate":"2023-05-02","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-02","modifiedBy":"FINCHAMB","dateModified":"2023-11-12","changeDescription":null,"administrativeNotes":"11/12/23 Released per PCDC-U of Chicago/Mei Li. BF;5/2/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173201","version":"1","longName":"Medications","context":"Pediatric Cancer"},{"publicId":"12173179","version":"1","longName":"Treatment","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"ROUTE","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Route","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FABB7E28-C9CC-280B-E053-731AD00AF625","latestVersionIndicator":"Yes","beginDate":"2023-05-02","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-02","modifiedBy":"FINCHAMB","dateModified":"2023-11-12","changeDescription":null,"administrativeNotes":"11/12/23 Released per PCDC-U of Chicago/Mei Li. BF;5/2/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"}}